Abstract
Background
Malignant fibrous histiocytoma (MFH) of soft tissue is one of the most common sarcoma in adulthood. However, only a few series have separately studied the clinical behavior and prognosis of this malignancy.
Methods
We retrospectively reviewed 61 patients treated for extremity soft tissue high-grade MFH. Four patients had a history of another malignancy and were excluded from analysis. In 12 referred patients with incomplete excision, re-excision of the tumor bed was offered. Clinical and treatment variables were analyzed for their impact on treatment complications, local recurrence (LR), metastatic disease (MD) and overall survival (OS).
Results
Four patients underwent primary amputation. Twenty-three patients necessitated a primary reconstructive procedure for wound closure. Wound healing complication (WHC) developed in 28.3 % of the limb sparing group of patients. LR developed in 11 patients (19.3 %), while 6 of them had second LR. Eighteen patients (31.5 %) developed MD, involving lung at least. Patients who developed MD <12 vs >12 months, died within 19.3 vs 8 months mean time (p < 0.05). Overall survivorship was 66.7 % at 5 years. No statistically significant variables were identified for LR, while multivariate analysis for MD revealed tumor size >5 cm as the only statistically significant variable. For OS, development of MD and age >70 years emerged as independent prognostic factors.
Conclusions
The overall prognosis is poor. LR, although can be managed with tumor re-excision, has high second recurrence rate. Increased tumor size is associated with shorter metastasis-free interval which significantly decreases survival.
Similar content being viewed by others
References
Ozzello L, Stout AP, Murray MR (1963) Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16:331–344
O’Brien JE, Stout AP (1964) Malignant fibrous xanthomas. Cancer 17:1445–1455
Fletcher CDM, Unni KK, Mertens F (eds) (2002) World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press, Lyon
Nascimento A, Chandrajit R (2008) Diagnosis and Management of Pleomorphic Sarcomas (So-Called ‘‘MFH’’) in Adults. J Surg Oncol 97:330–339
Oda Y, Tamiya S, Oshiro Y et al (2002) Reassessment and clinicopathological prognostic factors of malignant fibrous histiocytoma of soft parts. Pathol Int 52:595–606
Fletcher CDM, Gustafson P, Rydholm A, Ville′n H, Akerman M (2001) Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification. J Clin Oncol 19:3045–3050
Weiss SW, Enzinger FM (1978) Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41:2250–2266
Gibbs JF, Huang PP, Lee RJ et al (2001) Malignant fibrous histiocytoma: an institutional review. Cancer Invest 19:23–27
Sabesan T, Xuexi Wu, Qi Yongfa, Tang Pingzhang, Ilankovan V (2006) Malignant fibrous histiocytoma: Outcome of tumours in the head and neck compared with those in the trunk and extremities. Brit J Oral Maxillofac Surg 44:209–212
Murphey MD, Gross TM, Rosenthal HG (1994) From the archives of the AFIP, Musculoskeletal malignant fibrous histiocytoma: radiologic–pathologic correlation. Radiographics 14:807–826
Kontogeorgakos VA, Martinez S, Dodd L, Brigman B (2010) Extremity soft tissue sarcomas presented as hematomas. Arch Orthop Trauma Surg 130:1209–1214
American Joint Committee on Cancer (2002) AJCC cancer staging manual, 6th edn. Springer, New York
Geller DS, Hornicek FJ, Mankin HJ, Raskin KA (2007) Soft tissue sarcoma resection volume associated with wound-healing complications. Clin Orthop Relat Res 459:182–185
Hsu HC, Huang EY, Wang CJ (2004) Treatment Results and Prognostic Factors in Patients with Malignant Fibrous Histiocytoma. Acta Oncol 43:530–535
Belal A, Kandil A, Allam A et al (2002) Malignant fibrous histiocytoma: a retrospective study of 109 cases. Am J Clin Oncol 25:16–22
Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF (1999) Malignant fibrous histiocytoma of the extremity. Cancer 85:1765–1772
LeDoussal V, Coindre JM, Leroux A et al (1996) Prognostic factors for patients with localized primary malignant fibrous histiocytoma: a multicenter study of 216 patients with multivariate analysis. Cancer 77:1823–1830
Zagars GK, Ballo MT, Pisters PWT et al (2003) Prognostic factors for localized soft tissue sarcoma treated with conservation surgery and radiation therapy: an analysis of 1,225 patients. Cancer 97:2530–2543
Davis AM, Kandel RA, Wunder JS et al (1997) The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol 66:81–87
Giuliano AE, Eilber FR (1985) The rationale for planned reoperation after unplanned total excision of soft-tissue sarcomas. J Clin Oncol 3:1344–1348
Barwick WJ, Goldberg JA, Scully SP, Harrelson JM (1992) Vascularized tissue transfer for closure of irradiated wounds after soft tissue sarcoma resection. Ann Surg 216:591–595
Tseng JF, Ballo MT, Langstein HN et al (2006) The effect of preoperative radiotherapy and reconstructive surgery on wound complications after resection of extremity soft-tissue sarcomas. Ann Surg Oncol 13:1209–1215
Schultze-Mosgau S, Grabenbauer GG, Radespiel-Tröger M, Wiltfang J, Ries J, Neukam FW, Rödel F (2002) Vascularization in the transition area between free grafted soft tissues and pre-irradiated graft bed tissues following preoperative radiotherapy in the head and neck region. Head Neck 24:42–51
Al-Absi E, Farrokhyar F, Sharma R, Whelan K, Corbett T, Patel M, Ghert M (2010) A systematic review and meta-analysis of oncologic outcomes of pre- versus postoperative radiation in localized resectable soft-tissue sarcoma. Ann Surg Oncol 17:1367–1374
Stojadinovic A, Leung DH, Allen P, Lewis JJ, Jaques DP, Brennan MF (2002) Primary adult soft tissue sarcoma: time-dependent influence of prognostic variables. J Clin Oncol 20:4344–4352
Jebsen NL, Trovik CS, Bauer HC et al (2008) Radiotherapy to improve local control regardless of surgical margin and malignancy grade in extremity and trunk wall soft tissue sarcoma: a Scandinavian sarcoma group study. Int J Radiat Oncol Biol Phys 71:1196–1203
Pritchard DJ, Reiman HM, Turcotte RE, Ilstrup DM (1993) Malignant fibrous histiocytoma of the soft tissues of the trunk and extremities. Clin Orthop Relat Res 289:58–65
Zagars GK, Mullen JR, Pollack A (1996) Malignant fibrous histiocytoma: outcome and prognostic factors following conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 5:983–994
Lehnhardt M, Daigeler A, Homann HH et al (2009) MFH revisited: outcome after surgical treatment of undifferentiated pleomorphic or not otherwise specified (NOS) sarcomas of the extremities - an analysis of 140 patients. Langenbecks Arch Surg. 394:313–320
Eilber FC, Brennan MF, Riedel E, Alektiar KM, Antonescu CR, Singer S (2005) Prognostic factors for survival in patients with locally recurrent extremity soft tissue sarcomas. Ann Surg Oncol 12:228–236
Evans RA (1993) Soft tissue sarcoma: the enigma of local recurrence. J Surg Oncol 53(2):88–91
Ramanathan RC, A’Hern R, Fisher C, Thomas JM (2001) Prognostic index for extremity soft tissue sarcomas with isolated local recurrence. Ann Surg Oncol 8:278–289
Zagars GK, Ballo MT, Pisters PW, Pollock RE, Patel SR, Benjamin RS (2003) Prognostic factors for disease-specific survival after first relapse of soft-tissue sarcoma: analysis of 402 patients with disease relapse after initial conservative surgery and radiotherapy. Int J Radiat Oncol Biol Phys 57:739–747
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Vasileios, K.A., Eward, W.C. & Brigman, B.E. Surgical treatment and prognosis in patients with high-grade soft tissue malignant fibrous histiocytoma of the extremities. Arch Orthop Trauma Surg 132, 955–961 (2012). https://doi.org/10.1007/s00402-012-1510-y
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00402-012-1510-y